Understanding DNAI1: A Potential Drug Target Or Biomarker (G27019)

Target Name: DNAI1

NCBI ID: G27019

DNAI1

Understanding DNAI1: A Potential Drug Target Or Biomarker

DNAI1, also known as DNAI1 variant 1, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The DNAI1 gene is located on the X chromosome and is responsible for the production of a protein called DNAI1, which plays a role in regulating cell division and has been linked to various diseases.

One of the key challenges in studying DNAI1 is its location on the X chromosome, which means that it is only expressed in males. This has limited the availability of research studies on the protein, making it difficult to determine its function and potential as a drug target. However, research has shown that DNAI1 is involved in many important cellular processes, including cell division, apoptosis (programmed cell death), and inflammation.

One of the key functions of DNAI1 is its role in cell division. DNAI1 is involved in the regulation of the cell cycle, which is the process by which cells grow, divide, and replicate their genetic material. DNAI1 has been shown to play a role in the distribution of genetic material within the cell, as well as in the regulation of the cytoskeleton, which is the structure that gives cells shape and supports their internal organelles.

In addition to its role in cell division, DNAI1 has also been shown to be involved in apoptosis. Apoptosis is a natural process that helps the body eliminate damaged or dysfunctional cells, which can lead to a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. DNAI1 has been shown to play a role in regulating apoptosis, as well as in the regulation of cell survival and proliferation.

Furthermore, DNAI1 is involved in the regulation of inflammation. Chronic inflammation can contribute to a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. DNAI1 has been shown to play a role in the regulation of inflammatory responses, as well as in the regulation of immune cell function.

Overall, the study of DNAI1 has provided new insights into its role in various diseases. While more research is needed, the potential of DNAI1 as a drug target or biomarker is significant. As research continues to develop, it is likely that DNAI1 will be found to be involved in even more cellular processes, and its potential as a drug target or biomarker will continue to grow.

Protein Name: Dynein Axonemal Intermediate Chain 1

Functions: Part of the dynein complex of respiratory cilia

The "DNAI1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNAI1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets